Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4594979018 | Galantamine (as galantamine hydrobromide) 16 mg prolonged-release oral capsule | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4594980015 | Product containing precisely galantamine (as galantamine hydrobromide) 16 milligram/1 each prolonged-release oral capsule (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5303071000052116 | galantamin (som galantaminhydrobromid) 16 mg, depåkapsel | sv | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Galantamine (as galantamine hydrobromide) 16 mg prolonged-release oral capsule | Is a | Galantamine only product in oral dose form | true | Inferred relationship | Some | ||
| Galantamine (as galantamine hydrobromide) 16 mg prolonged-release oral capsule | Plays role | Antidementia therapeutic role (role) | true | Inferred relationship | Some | ||
| Galantamine (as galantamine hydrobromide) 16 mg prolonged-release oral capsule | Has precise active ingredient | Galantamine hydrobromide | true | Inferred relationship | Some | 1 | |
| Galantamine (as galantamine hydrobromide) 16 mg prolonged-release oral capsule | Has basis of strength substance (attribute) | Galantamine (substance) | true | Inferred relationship | Some | 1 | |
| Galantamine (as galantamine hydrobromide) 16 mg prolonged-release oral capsule | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Galantamine (as galantamine hydrobromide) 16 mg prolonged-release oral capsule | Has manufactured dose form | Prolonged-release oral capsule | true | Inferred relationship | Some | ||
| Galantamine (as galantamine hydrobromide) 16 mg prolonged-release oral capsule | Has unit of presentation | Capsule (unit of presentation) | true | Inferred relationship | Some | ||
| Galantamine (as galantamine hydrobromide) 16 mg prolonged-release oral capsule | Has presentation strength denominator unit (attribute) | Capsule (unit of presentation) | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
FHIR